1. Erlotinib turns straight hair curly

   News item 11 June 2022 Pages: 1 - 1

2. FDA approval of umbralisib withdrawn due to safety concerns

   News item 11 June 2022 Pages: 2 - 2

3. Nivolumab-related deafness

   News item 11 June 2022 Pages: 3 - 3

4. ADR reports for herbal medicines in the Netherlands

   Clinical study 11 June 2022 Pages: 4 - 4

5. AEs after homologous versus heterologous COVID-19 booster

   Clinical study 11 June 2022 Pages: 5 - 5

6. Antipsychotic-related impulse control disorders

   Clinical study 11 June 2022 Pages: 6 - 6

7. Montelukast-related nightmares

   Clinical study 11 June 2022 Pages: 7 - 7

8. Risk of SAEs with cholinesterase inhibitor use in elderly

   Clinical study 11 June 2022 Pages: 8 - 8

9. Safety of mRNA COVID-19 vaccines during pregnancy

   Clinical study 11 June 2022 Pages: 9 - 9

10. Standardised assessment of COVID-19 vaccine-related skin reactions

    Clinical study 11 June 2022 Pages: 10 - 10

11. Time to onset of drug-induced parkinsonism in Japanese patients

    Clinical study 11 June 2022 Pages: 11 - 11

12. Vaccination-associated cardiac adverse events rare

    Clinical study 11 June 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 11 June 2022 Pages: 13 - 13

14. Abncov2-cvlp-based-covid-2019-vaccine-adaptvac

    Case report 11 June 2022 Pages: 14 - 14

15. Ad26.COV2-S/elasomeran/tozinameran

    Case report 11 June 2022 Pages: 15 - 15

16. Adalimumab/methotrexate

    Case report 11 June 2022 Pages: 16 - 16

17. Adenosine/flecainide/metoprolol

    Case report 11 June 2022 Pages: 17 - 17

18. Afatinib

    Case report 11 June 2022 Pages: 18 - 18

19. Alcohol

    Case report 11 June 2022 Pages: 19 - 19

20. Alcohol/polyvinyl alcohol

    Case report 11 June 2022 Pages: 20 - 20

21. Alectinib/pralsetinib

    Case report 11 June 2022 Pages: 21 - 21

22. Alprostadil

    Case report 11 June 2022 Pages: 22 - 22

23. Alteplase

    Case report 11 June 2022 Pages: 23 - 23

24. Alteplase

    Case report 11 June 2022 Pages: 24 - 24

25. Amiodarone

    Case report 11 June 2022 Pages: 25 - 25

26. Amiodarone

    Case report 11 June 2022 Pages: 26 - 26

27. Amiodarone/dabigatran-etexilate

    Case report 11 June 2022 Pages: 27 - 27

28. Amiodarone/edoxaban

    Case report 11 June 2022 Pages: 28 - 28

29. Amiodarone/flecainide/sotalol

    Case report 11 June 2022 Pages: 29 - 29

30. Amitriptyline

    Case report 11 June 2022 Pages: 30 - 30

31. Amlodipine/irbesartan

    Case report 11 June 2022 Pages: 31 - 31

32. Amoxicillin/ampicillin

    Case report 11 June 2022 Pages: 32 - 32

33. Amoxicillin/clavulanic acid

    Case report 11 June 2022 Pages: 33 - 33

34. Amoxicillin/clavulanic acid/cefoxitin/nitrofurantoin

    Case report 11 June 2022 Pages: 34 - 34

35. Amphotericin-B-liposomal

    Case report 11 June 2022 Pages: 35 - 35

36. Amphotericin-B-liposomal/insulin

    Case report 11 June 2022 Pages: 36 - 36

37. Amphotericin-B-liposomal/prednisone/voriconazole

    Case report 11 June 2022 Pages: 37 - 37

38. Amphotericin-b/fluconazole

    Case report 11 June 2022 Pages: 38 - 38

39. Ampicillin/clindamycin

    Case report 11 June 2022 Pages: 39 - 39

40. Andexanet alfa

    Case report 11 June 2022 Pages: 40 - 40

41. Antibacterials/antifungals/parenteral-nutrition-supplements

    Case report 11 June 2022 Pages: 41 - 41

42. Antibiotics

    Case report 11 June 2022 Pages: 42 - 42

43. Antibiotics

    Case report 11 June 2022 Pages: 43 - 43

44. Antibiotics

    Case report 11 June 2022 Pages: 44 - 44

45. Antiepileptic drugs

    Case report 11 June 2022 Pages: 45 - 45

46. Antiepileptic drugs/glycopyrrolate

    Case report 11 June 2022 Pages: 46 - 46

47. Antiepileptic drugs/immune globulin/quinidine

    Case report 11 June 2022 Pages: 47 - 47

48. Antiepileptics

    Case report 11 June 2022 Pages: 48 - 48

49. Antifungals

    Case report 11 June 2022 Pages: 49 - 49

50. Antihypertensives

    Case report 11 June 2022 Pages: 50 - 50